Skip to main content
Tech.euFundingExplorerBeta

Thabor Therapeutics

Paris-based company developing an innovative treatment for patients living with chronic mucosal inflammatory diseases

Total raised
€2.0M
€2,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2022-07
latest 2022-07

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood22
base rate 30% for Other
  • Overdue vs cohort gap
  • Low backer re-investment

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2022-07-06Other€2.0MBpifranceView deal →

Investors

1

Similar companies

same sector or country